Market Tracker

10/31 10:00pm ET

Novo Nordisk A/S (NYSE:NVO)

During the Trading Day
45.18 -1.03 / -2.23%
Data as of 4:03pm ET
Day’s Change
During After-Hours   Switch to standard view »
44.87 -0.31 / -0.69%
 
Volume: 47.7K

Today’s Trading

Previous close46.21
Today’s open45.36
Day’s range45.09 - 45.56
Volume1,377,195
Average volume (3 months)1,346,502
Market cap$96.0B
Dividend yield1.84%
Data as of 4:03pm ET, 10/31/2014

Growth & Valuation

Earnings growth (last year)+23.61%
Earnings growth (this year)--
Earnings growth (next 5 years)+11.65%
Revenue growth (last year)+10.11%
P/E ratio--
Price/Sales6.64
Price/Book15.56

Competitors

 Today’s
change
Today’s
% change
ABBVAbbVie Inc+2.28+3.73%
BMYBristol-Myers Squibb...-0.79-1.34%
AZNAstraZeneca PLC+0.34+0.47%
CELGCelgene Corp+0.15+0.14%
Data as of 4:10pm ET, 10/31/2014

Financials

Last reporting dateOctober 30, 2014
EPS forecast (this quarter)$0.44
Annual revenue (last year)$14.9B
Annual profit (last year)$4.5B
Net profit margin30.13%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer
Lars Rebien Sørensen
President &
Chief Operating Officer
Kåre Schultz
Corporate headquarters
Bagsvrd, --

Forecasts